#probucol
New in @theinnovation.bsky.social! A polymerized probucol nanoformulation with neutrophil extracellular vesicle camouflage for cerebral ischemia-reperfusion injury therapy.
This study presents the development of ROS-responsive biomimetic polyprodrug #nanoparticles.
doi.org/10.1016/j.xi...
#medicine
January 18, 2025 at 4:43 AM
Repurposing probucol for prevention of dementia: a nationwide cohort study #NeuroDegeneration 🧪🧠
https://www.researchsquare.com/article/rs-10311061/latest
August 13, 2026 at 10:02 PM
2/3 Mitochondria are like tiny powerhouses in our cells. When they get damaged, it can lead to cell death. But probucol enhances mitophagy, a process that removes these damaged parts, potentially slowing down Parkinson's progression.
February 11, 2025 at 9:35 AM
1/3 Imagine a simple pill that could slow down Parkinson's! Researchers found that probucol, a cholesterol drug, can help remove damaged parts of cells called mitochondria. This could mean new hope for millions of people with Parkinson's.
February 11, 2025 at 9:35 AM
Effect of Probucol and Atorvastatin Treatment on the Self‐Care Ability of Acute Cerebral Infarction Patients: A Randomized Clinical Trial Study Br&Beh
Effect of Probucol and Atorvastatin Treatment on the Self‐Care Ability of Acute Cerebral Infarction Patients: A Randomized Clinical Trial Study
Brain and Behavior, Volume 15, Issue 5, May 2025.
dlvr.it
May 30, 2025 at 10:15 AM
Repurposing probucol for prevention of dementia: Evidence from a nationwide cohort study https://www.medrxiv.org/content/10.1101/2025.11.17.25340427v1
November 20, 2025 at 1:26 AM
Effects of HA1 (a Probucol Analogue) and ApoC3 siRNA on Lipoprotein-Amyloid Metabolism, Neurovascular Integrity and Cognitive Function in db/db Mice https://www.biorxiv.org/content/10.1101/2024.11.05.622070v1
Effects of HA1 (a Probucol Analogue) and ApoC3 siRNA on Lipoprotein-Amyloid Metabolism, Neurovascular Integrity and Cognitive Function in db/db Mice https://www.biorxiv.org/content/10.1101/2024.11.05.622070v1
Abstract Background and aims Chronically elevated levels of circulating lipoprotein-amyloid-beta (Ab
www.biorxiv.org
November 6, 2024 at 5:16 AM
Probucol mitigates high-fat diet-induced cognitive and social impairments through disruption of redox-inflammation association https://www.biorxiv.org/content/10.1101/2023.09.05.556289v1
Probucol mitigates high-fat diet-induced cognitive and social impairments through disruption of redox-inflammation association https://www.biorxiv.org/content/10.1101/2023.09.05.556289v1
Obesity and its detrimental metabolic consequences are commonly recognized as risk factors for impai
www.biorxiv.org
September 6, 2023 at 12:45 AM
Effects of HA1 (a Probucol Analogue) and ApoC3 siRNA on Lipoprotein-Amyloid Metabolism, Neurovascular Integrity and Cognitive Function in db/db Mice https://www.biorxiv.org/content/10.1101/2024.11.05.622070v1
Effects of HA1 (a Probucol Analogue) and ApoC3 siRNA on Lipoprotein-Amyloid Metabolism, Neurovascular Integrity and Cognitive Function in db/db Mice https://www.biorxiv.org/content/10.1101/2024.11.05.622070v1
Abstract Background and aims Chronically elevated levels of circulating lipoprotein-amyloid-beta (Ab
www.biorxiv.org
November 6, 2024 at 5:16 AM
Repurposing probucol for prevention of dementia: Evidence from a nationwide cohort study #NeuroDegeneration 🧪🧠
http://medrxiv.org/cgi/content/short/2025.11.17.25340427v1
November 20, 2025 at 8:02 AM
Effects of HA1 (a Probucol Analogue) and ApoC3 siRNA on Lipoprotein-Amyloid Metabolism, Neurovascular Integrity and Cognitive Function in db/db Mice #neurodegeneration
http://biorxiv.org/cgi/content/short/2024.11.05.622070v1
November 6, 2024 at 9:01 AM